Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Fine
Daniel F Martin
Peter Kirkpatrick

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Nature Reviews. Drug Discovery|March 18, 2005
Pegaptanib sodiumStuart L Fine, Daniel F Martin, Peter Kirkpatrick
The New England Journal of Medicine|June 4, 2010
Identifying and eliminating the roadblocks to comparative-effectiveness researchDaniel F Martin, Maureen G Maguire, Stuart L Fine
JAMA|August 27, 2014
Cost-related motivations for researchDaniel F Martin, Stuart L Fine, Maureen G Maguire
Clinical & Experimental Ophthalmology|March 29, 2012
Bevacizumab: not as good with more adverse reactions? ResponseDaniel F Martin, Maureen G Maguire, Stuart L Fine
Investigative Ophthalmology & Visual Science|October 27, 2006
Introducing Joshua L. Dunaief, the 2006 recipient of the Cogan AwardStuart L Fine
American Journal of Ophthalmology|March 16, 2005
Age-related macular degeneration 1969-2004: a 35-year personal perspectiveStuart L Fine
The New England Journal of Medicine|April 30, 2011
Ranibizumab and bevacizumab for neovascular age-related macular degeneration, Daniel F Martin, Maureen G Maguire, et al.
International Ophthalmology Clinics|January 24, 2007
Thermal laser treatment in AMD: therapeutic and prophylacticCatherine Cukras, Stuart L Fine
International Ophthalmology Clinics|January 24, 2007
Classification and grading system for age-related macular degenerationCatherine Cukras, Stuart L Fine
Clinical Interventions in Aging|June 9, 2009
Primary treatment of diabetic macular edemaTushar M Ranchod, Stuart L Fine
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Nature Reviews. Drug Discovery|March 18, 2005
Pegaptanib sodiumStuart L Fine, Daniel F Martin, Peter Kirkpatrick
The New England Journal of Medicine|June 4, 2010
Identifying and eliminating the roadblocks to comparative-effectiveness researchDaniel F Martin, Maureen G Maguire, Stuart L Fine
JAMA|August 27, 2014
Cost-related motivations for researchDaniel F Martin, Stuart L Fine, Maureen G Maguire
Clinical & Experimental Ophthalmology|March 29, 2012
Bevacizumab: not as good with more adverse reactions? ResponseDaniel F Martin, Maureen G Maguire, Stuart L Fine
Investigative Ophthalmology & Visual Science|October 27, 2006
Introducing Joshua L. Dunaief, the 2006 recipient of the Cogan AwardStuart L Fine
American Journal of Ophthalmology|March 16, 2005
Age-related macular degeneration 1969-2004: a 35-year personal perspectiveStuart L Fine
The New England Journal of Medicine|April 30, 2011
Ranibizumab and bevacizumab for neovascular age-related macular degeneration, Daniel F Martin, Maureen G Maguire, et al.
International Ophthalmology Clinics|January 24, 2007
Thermal laser treatment in AMD: therapeutic and prophylacticCatherine Cukras, Stuart L Fine
International Ophthalmology Clinics|January 24, 2007
Classification and grading system for age-related macular degenerationCatherine Cukras, Stuart L Fine
Clinical Interventions in Aging|June 9, 2009
Primary treatment of diabetic macular edemaTushar M Ranchod, Stuart L Fine
Pageof 26